Author

Naoko Iwata‐Yoshikawa

National Institute of Infectious DiseasesORCID 0000-0001-7818-686XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Haruaki KurasakiiD· 1 shared Haruhiko Ogawa· 1 shared Hidetomo Kitamura· 1 shared Hirofumi OhashiiD· 1 shared Junpei Yamamoto· 1 shared Kaho Shionoya· 1 shared Katsuma Matsui· 1 shared Kazutaka Nagatomo· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Haruaki KurasakiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintMar 6, 2026

A macrocyclic peptide-based fusion inhibitor targeting SARS-CoV-2 Spike S2 subunit

Hirofumi Ohashi, Tatsuro Kawamura, Masaki Ohuchi…·Koichi Watashi

This paper identifies PA-001, a macrocyclic peptide that inhibits SARS-CoV-2 infection by targeting the S2 subunit's FPPR region, showing broad antiviral activity and efficacy in animal models and clinical trials.

1 citation

humanmouse

𝕏 PostBluesky